Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO2 | P16083 | 3/20 | 0.39 |
| ▸ | HPGDS | O60760 | 3/20 | 0.36 |
| ▸ | HSD17B1 | P14061 | 6/20 | 0.35 |
| ▸ | HSD17B2 | P37059 | 6/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.34 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.34 |
| ▸ | ITGAV | P06756 | 2/20 | 0.34 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.34 |
| ▸ | ITGA5 | P08648 | 2/20 | 0.34 |
| ▸ | ITGB5 | P18084 | 2/20 | 0.34 |
| ▸ | IKBKB | O14920 | 2/20 | 0.33 |
| ▸ | CHUK | O15111 | 2/20 | 0.33 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15805958 | 0.94 | NQO2 (0.41) | NQO2HPGDSHSD17B1HSD17B2EPHX2 | |
| SCHEMBL15805912 | 0.90 | EPHX2 (0.37) | NQO2HPGDSHSD17B1HSD17B2EPHX2 | |
| SCHEMBL16169667 | 0.88 | NQO2 (0.37) | NQO2HPGDSHSD17B1HSD17B2EPHX2 | |
| SCHEMBL16169745 | 0.87 | MTNR1A (0.37) | CYP2D6 | |
| SCHEMBL15139160 | 0.86 | NQO2 (0.43) | NQO2HPGDSHSD17B1HSD17B2EPHX2 | |
| SCHEMBL16603498 | 0.84 | NQO2 (0.40) | NQO2 | |
| SCHEMBL15138993 | 0.80 | NOS1 (0.39) | CYP2D6 | |
| SCHEMBL15275016 | 0.79 | F10 (0.43) | CYP2D6 | |
| SCHEMBL16603473 | 0.78 | F10 (0.38) | NQO2 | |
| SCHEMBL16603474 | 0.77 | IKBKB (0.36) | NQO2HPGDSEPHX2IKBKBCHUK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140308317-A1 | Polymeric Compounds And Methods Of Making And Using The Same | CELLCEUTIX CORPORATION (US) | 2014-10-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140308317-A1 | Polymeric Compounds And Methods Of Making And Using The Same | ALG1, CD44, MUC1 | NQO2 2700/4885HPGDS 141/4885HSD17B1 3931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.